Targeted treatments for lung cancer: de-mystifying the science

Dr Vickers describes the faulty genes, pathways and proteins that drive small cell and non-small cell lung cancer. She also explains the scientific rationale behind targeted treatments in use and in development for these diseases, such as EGFR inhibitors, ALK and ROS1 inhibitors, B-Raf inhibitors, angiogenesis inhibitors and immunotherapy with checkpoint inhibitors.